Skip to main content
PureTech Health plc logo

PureTech Health plc — Investor Relations & Filings

Ticker · PRTC ISIN · GB00BPVG5C82 LEI · 213800LVPDNO2Z9T9I39 IL Manufacturing
Open in API
Filings indexed 1,319 across all filing types
Latest filing 2023-09-12 Transaction in Own Shar…
Country GB United Kingdom
Listing IL PRTC

About PureTech Health plc

https://puretechhealth.com/

PureTech Health is a clinical-stage biotherapeutics company dedicated to discovering, developing, and commercializing new classes of medicine for devastating diseases. The company's research and development engine focuses on advancing novel treatments by enhancing on-target efficacy, improving tolerability, or enabling oral administration of therapeutics with validated mechanisms. Its pipeline includes wholly-owned therapeutic candidates targeting a range of conditions, including idiopathic pulmonary fibrosis, neuropsychiatric disorders, and various cancers.

Recent filings

Filing Released Lang Actions
Transaction in Own Shares
Transaction in Own Shares Classification · 99% confidence The document explicitly states its purpose in the header: "Transaction in Own Shares". It details the purchase of ordinary shares as part of a "Share Buyback Programme" on a specific date (11 September 2023), including volume, highest, lowest, and VWAP prices. This directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS), which covers the company buying back its own shares. The RNS Number format also suggests a regulatory disclosure, but the content is highly specific to share repurchase activity.
2023-09-12 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is titled 'Transaction in Own Shares' and explicitly states that the company 'announces that it has purchased the following number of its ordinary shares... as part of its Share Buyback Programme'. It details the date, number, and price of shares purchased, and updates the total shares in treasury and in issue. This content directly corresponds to the definition of 'Transaction in Own Shares', which maps to the filing type code POS (Report of the company buying back or selling its own shares (share repurchase/issuance)). The RNS Number suggests it is a regulatory announcement, but the specific content dictates the POS classification over the general RNS fallback.
2023-09-11 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly states its purpose in the title section: 'Transaction in Own Shares' and details the purchase of ordinary shares as part of a 'Share Buyback Programme'. This directly corresponds to the definition of 'Transaction in Own Shares' (POS), which covers company buying back or selling its own shares (share repurchase/issuance). The RNS Number format and the presence of detailed transaction tables confirm it is a regulatory disclosure related to share capital changes, specifically repurchases.
2023-09-08 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is an RNS announcement from PureTech Health PLC dated September 7, 2023. The title explicitly states 'Transaction in Own Shares' and the content details the purchase of ordinary shares as part of a 'Share Buyback Programme'. This directly corresponds to the definition of a company reporting transactions in its own shares. Therefore, the appropriate filing type code is POS (Transaction in Own Shares).
2023-09-07 English
6-K
Transaction in Own Shares Classification · 100% confidence The document is a Form 6-K filed with the SEC by PureTech Health plc, reporting on the company's share repurchase program activity during August 2023. It details daily purchases of the company's own shares under the program, including volumes and prices, and references regulatory compliance with UK Listing Rules and EU regulations. The content focuses on the company's transactions in its own shares, specifically buybacks, rather than financial results, management changes, or other report types. The document length is 6823 characters, which is sufficient to contain substantive transaction data. Therefore, this filing is best classified as a Transaction in Own Shares (POS) report, which covers company buyback activities.
2023-09-06 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is an RNS announcement from PureTech Health PLC dated September 6, 2023. The title explicitly states 'Transaction in Own Shares' and details the purchase of ordinary shares as part of a 'Share Buyback Programme'. This directly corresponds to the definition of a company reporting the repurchase or sale of its own shares. Therefore, the appropriate filing type is 'Transaction in Own Shares' (POS).
2023-09-06 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.